Ladenburg Thalmann Financial Services’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $23K | Buy |
590
+16
| +3% | +$624 | ﹤0.01% | 4067 |
|
|
2019
Q3 | $14K | Hold |
574
| – | – | ﹤0.01% | 4229 |
|
|
2019
Q2 | $21K | Hold |
574
| – | – | ﹤0.01% | 4022 |
|
|
2019
Q1 | $25K | Sell |
574
-39
| -6% | -$1.7K | ﹤0.01% | 3853 |
|
|
2018
Q4 | $32K | Sell |
613
-104
| -15% | -$5.43K | ﹤0.01% | 3564 |
|
|
2018
Q3 | $48K | Sell |
717
-3,488
| -83% | -$234K | ﹤0.01% | 3338 |
|
|
2018
Q2 | $237K | Hold |
4,205
| – | – | ﹤0.01% | 2100 |
|
|
2018
Q1 | $237K | Buy |
4,205
+12
| +0.3% | +$676 | ﹤0.01% | 2100 |
|
|
2017
Q4 | $208K | Sell |
4,193
-104
| -2% | -$5.16K | ﹤0.01% | 2191 |
|
|
2017
Q3 | $327K | Buy |
4,297
+157
| +4% | +$11.9K | ﹤0.01% | 1735 |
|
|
2017
Q2 | $389K | Buy |
4,140
+194
| +5% | +$18.2K | ﹤0.01% | 1551 |
|
|
2017
Q1 | $314K | Buy |
3,946
+3,311
| +521% | +$263K | ﹤0.01% | 1611 |
|
|
2016
Q4 | $60K | Buy |
635
+44
| +7% | +$4.16K | ﹤0.01% | 2707 |
|
|
2016
Q3 | $67K | Buy |
591
+45
| +8% | +$5.1K | ﹤0.01% | 2550 |
|
|
2016
Q2 | $60K | Sell |
546
-16
| -3% | -$1.76K | ﹤0.01% | 2541 |
|
|
2016
Q1 | $58K | Buy |
562
+172
| +44% | +$17.8K | ﹤0.01% | 2479 |
|
|
2015
Q4 | $32K | Buy |
390
+63
| +19% | +$5.17K | ﹤0.01% | 2893 |
|
|
2015
Q3 | $23K | Buy |
327
+17
| +5% | +$1.2K | ﹤0.01% | 3016 |
|
|
2015
Q2 | $30K | Buy |
310
+166
| +115% | +$16.1K | ﹤0.01% | 2955 |
|
|
2015
Q1 | $14K | Buy |
144
+25
| +21% | +$2.43K | ﹤0.01% | 3411 |
|
|
2014
Q4 | $13K | Hold |
119
| – | – | ﹤0.01% | 3248 |
|
|
2014
Q3 | $14K | Sell |
119
-31
| -21% | -$3.65K | ﹤0.01% | 2894 |
|
|
2014
Q2 | $19K | Hold |
150
| – | – | ﹤0.01% | 2699 |
|
|
2014
Q1 | $24K | Buy |
150
+42
| +39% | +$6.72K | ﹤0.01% | 2448 |
|
|
2013
Q4 | $15K | Buy |
108
+25
| +30% | +$3.47K | ﹤0.01% | 2705 |
|
|
2013
Q3 | $8K | Buy |
+83
| New | +$8K | ﹤0.01% | 2958 |
|